Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

13.07
-0.5400-3.97%
Post-market: 13.100.0300+0.23%19:58 EDT
Volume:5.65M
Turnover:74.04M
Market Cap:1.29B
PE:-2.24
High:13.59
Open:13.56
Low:12.88
Close:13.61
52wk High:39.89
52wk Low:12.88
Shares:98.32M
Float Shares:80.72M
Volume Ratio:1.21
T/O Rate:7.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-4.42
PE(LYR):-2.24

Loading ...

Ultragenyx Unit Amlogenyx Presents at Wells Fargo Healthcare Conference Sept. 8

Reuters
·
Sep 02

Ultragenyx announces publication of Phase 3 Genglycos trial results

TIPRANKS
·
Sep 02

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of Genglycos™ (Also Known as Dtx401) Aav Gene Therapy in Gsdia in the Journal of Inherited Metabolic Disease

THOMSON REUTERS
·
Sep 02

Ultragenyx Grants 45,984 Inducement RSUs to 23 New Hires

Reuters
·
Aug 26

Ultragenyx Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 26

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 26

Ultragenyx Pharma Price Target Raised to $80.00/Share from $75.00 by JP Morgan

Dow Jones
·
Aug 25

Ultragenyx Pharmaceutical Inc. : Morgan Stanley Raises Target Price to $74 from $67

THOMSON REUTERS
·
Aug 21

Analysts’ Top Healthcare Picks: Evaxion Biotech (EVAX), Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Aug 21

U.S. Stocks on the MOVE-Apple, Hims & Hers Health, Sysco

Reuters
·
Aug 20

Ultragenyx Pharmaceutical (RARE) Stock Jumps 9% on Accelerated FDA Approval

TIPRANKS
·
Aug 20

Sector Update: Healthcare

MT Newswires Live
·
Aug 20

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)

TIPRANKS
·
Aug 20

Cantor Fitzgerald Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Aug 20

U.S. Stocks on the MOVE-Walmart, Atour Lifestyle, Wolfspeed

Reuters
·
Aug 20

Ultragenyx Pharmaceutical Shares up 8.6% Premarket After Securing FDA Nod for Rare Metabolic Disorder Gene Therapy

THOMSON REUTERS
·
Aug 20

Ultragenyx price target raised to $83 from $81 at Canaccord

TIPRANKS
·
Aug 20

Ultragenyx Pharma Price Target Raised to $103.00/Share from $96.00 by Cantor Fitzgerald

Dow Jones
·
Aug 20

Ultragenyx price target raised to $58 from $45 at Citi

TIPRANKS
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20